Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2019
The aim of this study is to determine the efficacy and safety of Beta-1,3/1,6-D-Glucan from mycelium extract of Ganoderma lucidum on ulcerative colitis
Epistemonikos ID: deb0f8695af3bdae18b93c29d289419ac72535ea
First added on: Mar 23, 2022